Accupril and Tendonitis - a phase IV clinical study of FDA data

Summary:

Tendonitis is reported as a side effect among people who take Accupril (quinapril hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Lasix, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Tendonitis when taking Accupril. It is created by eHealthMe based on reports of 13,164 people who have side effects when taking Accupril from the FDA, and is updated regularly.

What is Accupril?

Accupril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,404 Accupril users. Check the latest studies of Accupril.

What is Tendonitis?

Tendonitis (a condition that causes pain and swelling of tendons) is found to be associated with 1,097 drugs and 1,272 conditions by eHealthMe. Check the latest studies of Tendonitis.

On Jul, 16, 2026

13,164 people reported to have side effects when taking Accupril.
Among them, 69 people (0.52%) have Tendonitis.

Among these 69 people:

How long have people been on Accupril when they have Tendonitis? *

What is the gender of people who have Tendonitis when taking Accupril? *

female: 65.22 %
male: 34.78 %

What is the age of people who have Tendonitis when taking Accupril? *

What are other drugs people take besides Accupril? *

What are other side effects people have besides Tendonitis? *

Intervertebral Disc Degeneration (spinal disc degeneration): 35 people, 50.72%
Stress And Anxiety: 35 people, 50.72%
Injury: 32 people, 46.38%
Cardiac Failure Congestive: 31 people, 44.93%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 30 people, 43.48%
Pain In Extremity: 30 people, 43.48%
Oedema Peripheral (superficial swelling): 29 people, 42.03%
Pain: 29 people, 42.03%
Back Pain: 29 people, 42.03%
Pneumonia: 28 people, 40.58%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 19 people, 27.54%
Metastatic Neoplasm (spreadable cancer tumour): 18 people, 26.09%
Diabetes: 13 people, 18.84%
Hypersensitivity: 12 people, 17.39%
Breast Cancer: 8 people, 11.59%
Metastases To Bone (cancer spreads to bone): 8 people, 11.59%
Depression: 4 people, 5.80%
High Blood Cholesterol: 3 people, 4.35%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 3 people, 4.35%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Accupril and have Tendonitis?

- Check whether Tendonitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Accupril:

Accupril (13,404 reports)

Tendonitis treatments and more:

Tendonitis (23,484 reports)

Browse all side effects of Accupril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tendonitis:

Tendonitis (1,097 drugs)

Browse all the conditions that are associated with Tendonitis:

Tendonitis (1,272 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on quinapril hydrochloride (the active ingredients of Accupril) and Accupril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.